Christian Mayr

1.3k total citations
58 papers, 1.1k citations indexed

About

Christian Mayr is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Christian Mayr has authored 58 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 29 papers in Surgery and 27 papers in Oncology. Recurrent topics in Christian Mayr's work include Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers), MicroRNA in disease regulation (9 papers) and Epigenetics and DNA Methylation (9 papers). Christian Mayr is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers), MicroRNA in disease regulation (9 papers) and Epigenetics and DNA Methylation (9 papers). Christian Mayr collaborates with scholars based in Austria, Germany and United States. Christian Mayr's co-authors include Tobias Kiesslich, Daniel Neureiter, Johannes Büchner, Andrej Wagner, Martin Pichler, Martin Jakab, Frieder Berr, Matthias Ocker, E. Klieser and Markus Ritter and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Christian Mayr

57 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christian Mayr Austria 20 632 305 222 204 149 58 1.1k
Loris Bertazza Italy 21 373 0.6× 281 0.9× 256 1.2× 140 0.7× 97 0.7× 60 1.1k
Yuanfeng Gong China 18 475 0.8× 317 1.0× 321 1.4× 223 1.1× 129 0.9× 50 1.0k
Chikashi Nakanishi Japan 13 442 0.7× 220 0.7× 314 1.4× 205 1.0× 65 0.4× 49 988
Krzysztof Goryca Poland 19 762 1.2× 283 0.9× 326 1.5× 142 0.7× 217 1.5× 69 1.3k
Ki Beom Bae South Korea 20 526 0.8× 309 1.0× 142 0.6× 243 1.2× 129 0.9× 69 1.2k
Valentina Grossi Italy 17 647 1.0× 216 0.7× 221 1.0× 97 0.5× 195 1.3× 49 1.0k
Yanping Gong China 21 517 0.8× 219 0.7× 201 0.9× 266 1.3× 86 0.6× 54 1.1k
Megumi Baba Japan 19 395 0.6× 294 1.0× 224 1.0× 167 0.8× 197 1.3× 48 977
Soon Auck Hong South Korea 15 369 0.6× 256 0.8× 209 0.9× 136 0.7× 216 1.4× 90 967

Countries citing papers authored by Christian Mayr

Since Specialization
Citations

This map shows the geographic impact of Christian Mayr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Mayr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Mayr more than expected).

Fields of papers citing papers by Christian Mayr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Mayr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Mayr. The network helps show where Christian Mayr may publish in the future.

Co-authorship network of co-authors of Christian Mayr

This figure shows the co-authorship network connecting the top 25 collaborators of Christian Mayr. A scholar is included among the top collaborators of Christian Mayr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian Mayr. Christian Mayr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oberhuber, Rupert, et al.. (2025). The importance of preclinical models for cholangiocarcinoma drug discovery. Expert Opinion on Drug Discovery. 20(2). 205–216. 2 indexed citations
2.
Kiesslich, Tobias, Matthias Ocker, Martina Winklmayr, et al.. (2024). The efficacy of ferroptosis-inducing compounds IKE and RSL3 correlates with the expression of ferroptotic pathway regulators CD71 and SLC7A11 in biliary tract cancer cells. PLoS ONE. 19(4). e0302050–e0302050. 4 indexed citations
3.
Mayr, Christian, Tobias Kiesslich, Marlena Beyreis, et al.. (2023). Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells. PLoS ONE. 18(6). e0287769–e0287769. 5 indexed citations
5.
Neureiter, Daniel, Marlena Beyreis, Markus Ritter, et al.. (2023). Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer. Cancers. 15(5). 1569–1569. 13 indexed citations
6.
Klieser, E., et al.. (2023). HDACs as an emerging target in endocrine tumors: a comprehensive review. Expert Review of Endocrinology & Metabolism. 18(2). 143–154. 5 indexed citations
7.
Ocker, Matthias, Christian Mayr, Sebastian Stintzing, et al.. (2022). Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation. Cancers. 14(7). 1826–1826. 45 indexed citations
8.
Mayr, Christian, Tobias Kiesslich, Marlena Beyreis, et al.. (2021). HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer. Cancers. 13(15). 3862–3862. 22 indexed citations
9.
Neureiter, Daniel, Christian Mayr, & Tobias Kiesslich. (2021). The challenges of combinatory immunotherapy for biliary tract cancer. Expert Opinion on Investigational Drugs. 30(6). 591–594. 1 indexed citations
10.
Neureiter, Daniel, Markus Ritter, Martin Jakab, et al.. (2020). Long Non-Coding RNAs in Biliary Tract Cancer—An Up-to-Date Review. Journal of Clinical Medicine. 9(4). 1200–1200. 10 indexed citations
11.
Mayr, Christian, Marlena Beyreis, Martin Gaisberger, et al.. (2018). Miniaturization of the Clonogenic Assay Using Confluence Measurement. International Journal of Molecular Sciences. 19(3). 724–724. 9 indexed citations
12.
Helm, Katharina, Marlena Beyreis, Christian Mayr, et al.. (2017). In Vitro Cell Death Discrimination and Screening Method by Simple and Cost-Effective Viability Analysis. Cellular Physiology and Biochemistry. 41(3). 1011–1019. 21 indexed citations
13.
Mayr, Christian, Matthias Ocker, Markus Ritter, et al.. (2017). Biliary tract cancer stem cells - translational options and challenges. World Journal of Gastroenterology. 23(14). 2470–2470. 11 indexed citations
14.
Klieser, E., Stefan Stättner, Florian Primavesi, et al.. (2017). Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome. Human Pathology. 65. 41–52. 47 indexed citations
15.
Klieser, E., Christian Mayr, Tarkan Jäger, et al.. (2016). Differential role of Hedgehog signaling in human pancreatic (patho-) physiology: An up to date review. World Journal of Gastrointestinal Pathophysiology. 7(2). 199–199. 18 indexed citations
16.
Mayr, Christian, Daniel Neureiter, Martin Pichler, et al.. (2015). Cytotoxic effects of chemokine receptor 4 inhibition by AMD3100 in biliary tract cancer cells: Potential drug synergism with gemcitabine. Molecular Medicine Reports. 12(2). 2247–2252. 8 indexed citations
17.
Mayr, Christian, Arnika Kathleen Wagner, Marlena Beyreis, et al.. (2015). Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest. Zeitschrift für Gastroenterologie. 53(5). 1 indexed citations
18.
Mayr, Christian, Andrej Wagner, Daniela Bruckner, et al.. (2015). The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells. Oncotarget. 7(1). 745–758. 35 indexed citations
19.
Mayr, Christian, Andrej Wagner, Daniel Neureiter, et al.. (2015). The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells. BMC Complementary and Alternative Medicine. 15(1). 194–194. 59 indexed citations
20.
Scheibel, Thomas, et al.. (1997). ATP-binding Properties of Human Hsp90. Journal of Biological Chemistry. 272(30). 18608–18613. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026